OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
2013 · The Journal of Headache and Pain · 1 citations
https://doi.org/10.1186/1129-2377-14-s1-p199
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
2.0K
Citations
4
h-index
2
i10-index
RE DeGryse is an academic researcher from Allergan (United States). The author has contributed to research in topics: Migraine and Headache Studies & Botulinum Toxin and Related Neurological Disorders & Ophthalmology and Eye Disorders. The author has an h-index of 4, co-authored 10 publications.
Click to start Chat